Basel Medical (BMGL) Cash & Current Investments (2023 - 2025)
Basel Medical (BMGL) posted Cash & Current Investments of $1.0 million for Q4 2025, down 55.69% sequentially from $2.3 million in Q2 2025, and down 46.88% YoY from $2.0 million in Q4 2024.
Powered by 
Analysis
Basel Medical (BMGL) Cash & Current Investments (2023 - 2025) Analysis & Trends
Basel Medical has reported Cash & Current Investments for 2 years, with the latest figure at $1.0 million in Q4 2025.
- Quarterly Cash & Current Investments fell 46.88% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (down 46.88% YoY) and the FY2025 annual result came in at $2.3 million, up 59.34% from the prior year.
- Cash & Current Investments fell to $1.0 million in Q4 2025 per BMGL's latest filing, from $2.3 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $2.3 million in Q2 2025 and troughed at $1.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 89.74 Bn | 88.73 Bn | 15.19 Bn | 1.01 Bn |
| 2 | Tenet Healthcare | 22.14 Bn | 19.97 Bn | 4.45 Bn | 2.17 Bn |
| 3 | Encompass Health | 12.09 Bn | 11.95 Bn | 1.34 Bn | 133.50 Mn |
| 4 | Davita | 11.86 Bn | 11.17 Bn | 1.16 Bn | 688.88 Mn |
| 5 | Universal Health Services | 10.14 Bn | 10.00 Bn | 3.29 Bn | 138.80 Mn |
| 6 | Ensign | 9.91 Bn | 9.59 Bn | 306.24 Mn | 320.84 Mn |
| 7 | Chemed | 6.89 Bn | 6.85 Bn | 221.47 Mn | 40.22 Mn |
| 8 | Pacs | 6.74 Bn | 6.58 Bn | 338.46 Mn | 164.45 Mn |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.15 Bn | 192.10 Mn | 158.04 Mn |
| 10 | Basel Medical | 7.33 Mn | 6.54 Mn | - | 1.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.04 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.22 Mn |